CleanCap® mRNA Capping Reagent

CleanCap® mRNA Capping Reagent
Product Description

CleanCap technology is a “one-pot” solution that reduces the number of steps, equipment required, and time to produce a 5’ Cap 1 mRNA structure with 95% efficiency, providing a modern alternative to enzymatic capping. Available in GMP grade, CleanCap reagents offer an immediate solution for swiftly scaling from clinical to commercial.

TriLink Biotechnologies

  • US
  • 2022
    On CPHI since

TriLink Biotechnologies

  • US
  • 2022
    On CPHI since

More Products from TriLink Biotechnologies (3)

  • Custom mRNA Synthesis

    Product Custom mRNA Synthesis

    Since 2012, TriLink has been the industry leader in custom messenger RNA (mRNA) synthesis for research and clinical applications. We manufacture non-coding RNAs and provide tailored synthesis at milligram to multigram scales, with lengths ranging from a few hundred nucleotides to greater than 10 kilobases....
  • GMP Manufacturing Services

    Product GMP Manufacturing Services

    TriLink operates a state-of-the-art Current Good Manufacturing Practice (cGMP) production facility. As the leading manufacturer of mRNA, nucleotides, nucleoside triphosphates, and oligos, our unparalleled experience, technical expertise, and scalability make us an ideal partner for clinical or preclinical ...
  • Nucleoside Triphosphates & Nucleotides

    Product Nucleoside Triphosphates & Nucleotides

    TriLink offers a wide selection of modified nucleoside triphosphates (NTPs) to suit your application needs. We stock over 150 modified NTPs, including aminoallyl, biotin, 2' fluoro, and dye-labeled nucleotides. In addition, we offer specialty modified nucleotides such as 5'-3' bisphosphates, a series of mo...